Literature DB >> 20431949

Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population.

Efrat Broide1, Andrei Schopan, Michael Zaretsky, Nimrod Alain Kimchi, Michael Shapiro, Eitan Scapa.   

Abstract

BACKGROUND: Patients with Crohn's disease might have accelerated atherosclerosis due to: chronic systemic inflammation, metabolic changes or prolonged steroid treatment. AIMS: The aim of this study was to assess the risk of sub-clinical atherosclerosis in Crohn's disease, by measuring the intima-media thickness and peak systolic velocity of the common carotid artery.
METHODS: Fifty Crohn's disease patients aged between 20 and 45 years were compared to 25 controls. Patients with a family history of cardiovascular diseases or a known risk for atherosclerosis were excluded. All participants underwent nutritional assessment. Carotid artery ultrasonography was performed and intima-media thickness and peak systolic velocity were measured, proximal to the common carotid bifurcation. Clinical data and laboratory parameters (hemoglobin, highly sensitive C-reactive protein, and plasma homocysteine) were determined.
RESULTS: No significant differences between the groups were found for intima-media thickness or peak systolic velocity. Multiple regression analysis revealed a positive correlation of intima-media thickness with older age. Peak systolic velocity was negatively associated with age.
CONCLUSIONS: Crohn's disease patients do not have an increased risk for developing early atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431949     DOI: 10.1007/s10620-010-1235-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Acute myocardial infarction in a young woman with severe ulcerative colitis.

Authors:  Bülent Mutlu; Cem M H Ermeydan; Feruze Enç; Hakan Fotbolcu; Onur Demirkol; Fatih Bayrak; Yelda Basaran
Journal:  Int J Cardiol       Date:  2002-05       Impact factor: 4.164

4.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

5.  The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.

Authors:  P Jousilahti; V Salomaa; V Rasi; E Vahtera; T Palosuo
Journal:  Atherosclerosis       Date:  2001-06       Impact factor: 5.162

6.  Inflammatory bowel disease promotes venous thrombosis earlier in life.

Authors:  O Grip; P J Svensson; S Lindgren
Journal:  Scand J Gastroenterol       Date:  2000-06       Impact factor: 2.423

Review 7.  Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis.

Authors:  Spencer D Dorn; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

8.  Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

Authors:  Yong-Beom Park; Chul-Woo Ahn; Hyon K Choi; Seung-Hoon Lee; Byung-Hyun In; Hyun-Chul Lee; Chung-Mo Nam; Soo-Kon Lee
Journal:  Arthritis Rheum       Date:  2002-07

9.  Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

Authors:  Markus C Stühlinger; Roberta K Oka; Eric E Graf; Isabella Schmölzer; Barbara M Upson; Om Kapoor; Andrzej Szuba; M Rene Malinow; Thomas C Wascher; Otmar Pachinger; John P Cooke
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

Review 10.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

View more
  8 in total

1.  Evaluation of early atherosclerosis in patients with inflammatory bowel disease.

Authors:  Hasan Kayahan; Ismail Sari; Nesat Cullu; Fahize Yuksel; Serdal Demir; Mesut Akarsu; Yigit Goktay; Belkis Unsal; Hale Akpinar
Journal:  Dig Dis Sci       Date:  2012-04-01       Impact factor: 3.199

Review 2.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Hao Wu; Meihua Xu; Hong Hao; Michael A Hill; Canxia Xu; Zhenguo Liu
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

Review 4.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

Authors:  Dorota Cibor; Renata Domagala-Rodacka; Tomasz Rodacki; Artur Jurczyszyn; Tomasz Mach; Danuta Owczarek
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Pulse Wave Velocity, Intima Media Thickness, and Flow-mediated Dilatation in Patients with Normotensive Normoglycemic Inflammatory Bowel Disease.

Authors:  Kadir Ozturk; Ahmet Kerem Guler; Mehmet Cakir; Alptug Ozen; Hakan Demirci; Turker Turker; Seref Demirbas; Ahmet Uygun; Mustafa Gulsen; Sait Bagci
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

6.  Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease.

Authors:  Elżbieta Pac-Kożuchowska; Paulina Krawiec; Agnieszka Mroczkowska-Juchkiewicz; Agnieszka Pawłowska-Kamieniak; Katarzyna Kominek
Journal:  Med Sci Monit       Date:  2016-05-06

7.  Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.

Authors:  Yusuf Üstün; Serta Kilincalp; Şahin Çoban; Yusuf Coşkun; İlhami Yüksel; Aydan Ongun; İrfan Soykan; Mehmet Bektaş; Murat Törüner; Hülya Çetinkaya; Necati Örmeci
Journal:  Med Sci Monit       Date:  2016-10-24

Review 8.  Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets.

Authors:  Antonietta Gerarda Gravina; Marcello Dallio; Mario Masarone; Valerio Rosato; Andrea Aglitti; Marcello Persico; Carmelina Loguercio; Alessandro Federico
Journal:  Oxid Med Cell Longev       Date:  2018-04-12       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.